MTOR and neoplasm: Many data are now suggesting that these enzymes are critical for intima and adventitia neoplasia, EndoMt transition and reduction in inflammation; the intricacy of PI3K/AKT/mTOR signalling organization can suite the challenge for discovering new therapeutic uses of PI3K/AKT/mTOR inhibitors in AVF.